Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE)

Bonn, North Rhine-Westphalia 53127

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Alzheimer's Disease Dementia, Mild Cognitive Impairment Due to Alzheimer's Disease, Spinocerebellar Ataxia Type 3

Studies at this site

• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 — Stopped early